Le Lézard
Classified in: Tourism and vacations, Health, Covid-19 virus
Subject: AVO

WTTC calls on the CDC to stop "singling out" the cruise industry with harmful and unnecessary measures


LONDON, Jan. 19, 2022 /PRNewswire/ -- Speaking at the Fitur trade fair in Madrid Spain, Julia Simpson, WTTC President & CEO said:

"While we welcome the expiration of the CDC's conditional sail order, its decision to continue elevated travel health notices is nonsensical.  

"The cruise industry has proven time and again that its enhanced health and safety protocols consistently achieve significantly lower rates of COVID-19 occurrence than onshore.

"WTTC calls upon the CDC to stop singling out the cruise industry with harmful and unnecessary measures. Cruise lines have an excellent record for health and safety, and cruising continues to offer extraordinary travel experiences."

SOURCE World Travel & Tourism Council


These press releases may also interest you

at 22:15
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 19:59
Genomma Lab Internacional Announces Results for the First Quarter 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. Reports Results for First Quarter ended March 31, 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis Announces Transfer of ADSs to OTC Market
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne Reports First Quarter 2024 Results
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Reports First Quarter 2024 Results
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...

More news about Covid-19 virus...


News published on and distributed by: